Intravenous pharmacokinetics, local tolerability, and hemolysis of an SBE7‐β‐cyclodextrin formulation of the neurokinin‐1 receptor antagonist vestipitant

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 130-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subcutaneous Interferon-β-1a: New Formulation

By McKeage Kate   Wagstaff Antona J.  

CNS Drugs, Vol. 21, Iss. 10, 2007-01 ,pp. : 871-876

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 123-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega‐3‐Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single‐Blind, Randomized, Placebo‐Controlled Trial

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 177-187

John Wiley & Sons Inc

Access to resources Recommend Favorite